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Abstract
The precision and repeatability offered by computer-aided design and computer-numerically
controlled techniques in biofabrication processes is quickly becoming an industry standard.However,
many hurdles still exist before these techniques can be used in research laboratories for cellular and
molecular biology applications. Extrusion-based bioprinting systems have been characterized by high
development costs, injector clogging, difficulty achieving small cell number deposits, decreased cell
viability, and altered cell function post-printing. To circumvent the high-price barrier to entry of
conventional bioprinters, we designed and 3Dprinted components for the adaptation of an
inexpensive ‘off-the-shelf’ commercially available 3Dprinter.We also demonstrate via goal based
computer simulations that the needle geometries of conventional commercially standardized,
‘luer-lock’ syringe-needle systems causemany of the issues plaguing conventional bioprinters. To
address these performance limitationswe optimized flowwithin severalmicroneedle geometries,
which revealed a short tapered injector designwithminimal cylindrical needle lengthwas ideal to
minimize cell strain and accretion.We then experimentally quantified these geometries using pulled
glassmicrocapillary pipettes and ourmodified, low-cost 3D printer. This systems performance
validated ourmodels exhibiting: reduced clogging, single cell print resolution, andmaintenance of cell
viability without the use of a sacrificial vehicle. Using this systemwe show the successful printing of
human induced pluripotent stem cells (hiPSCs) intoGeltrex and note their retention of a pluripotent
state 7 d post printing.We also show embryoid body differentiation of hiPSC by injection into
differentiation conducive environments, whereinwe observed continuous growth, emergence of
various evaginations, and post-printing gene expression indicative of the presence of all three germ
layers. These data demonstrate an accessible open-source 3Dbioprinter capable of serving the needs
of any laboratory interested in 3D cellular interactions and tissue engineering.
1. Introduction
Bioprinting enables the high-precision, high-accuracy,
and high-throughput generation of biological con-
structs that can contain: extra-cellular matrix scaf-
folds, cells, and biochemical factors in three-
dimensions (3D). Due to these advantages, bioprinters
hold the promise of establishing systems that more
closely mimic the human in vivo microenvironment
than animal models and current 2D cell culture
environments [1, 2]. Great progress has been made in
the field of tissue engineering and regenerative medi-
cine due to the emergence of a wide range of 3D
multifunctional devices which employ extrusion-
based technologies to further the development of
advanced materials that require proper pre and post-
processing fabrication of 3D structures [3–7]. While
capable of generating high-throughput experimental
designs to answer difficult biological questions, the
technology has remained inaccessible tomost research
labs due to the initial investment andoperational costs.
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custom built 3D bioprinters yields high lab-to-lab
variability resulting in unpredictable experimental
outcomes, generating some unease surrounding their
implementation.
The dominant techniques in microextrusion bio-
printing use valve-based pneumatic or gear-driven
actuator extrusion systems to drive cell suspensions
out of a micro-needle tip. Numerous studies have
noted needle diameters under 150 μm are not ideal
because they are prone to frequent needle clogging
[8, 9]. Naturally, the print resolutions of these systems
are largely dependent on the diameter and flow rate at
the needle tip. Therefore, despite having highly accu-
rate/precise single μm positioning features, the
majority of microextrusion bioprinters are limited to
150 μm wide print resolutions. In addition to clog-
ging, previous reports indicate process-induced
damage can lead to a significant source of cell death
and unexpected post-printing phenotypes [10–16].
Therefore, any design that alleviates clogging and pro-
cess-induced damage while simultaneously increasing
print resolution to the sub-150 μm level would be
highly advantageous.
Furthermore, the impact of these systems onmore
sensitive cell types has been understudied. One extre-
mely promising cell type prone to defects upon physi-
cal manipulation is induced pluripotent stem cells
(iPSCs). iPSCs are advantageous in both disease mod-
eling and tissue engineering as they have the ability to
self-renew indefinitely or differentiate into any cell
type of all three germ layers [17]. A significant chal-
lenge for the implementation of iPSCs into bioprint-
ing is the multivariate nature of the differentiation
process. When culture conditions permit differentia-
tion, iPSC clumps will initially form spheroids, which
then differentiate into embryoid bodies (EBs) that
resemble early stages of embryogenesis. It has been
shown that the initial size of the EB aggregate is a cri-
tical factor in controlling differentiation [18]. Addi-
tionally, mechanically induced stem cell
differentiation has been attained through application
of mechanical forces including stretch, strain, com-
pression, and shear stress [19]. This awareness has led
to the development of methods to encapsulate cells
through the use of hydrogel-vehicle systems to alter
the distribution of damaging mechanical forces
experienced during flow. Yet, recent studies indicate
these systems do not offer complete protection from
damaging forces, and could ultimately lead to unwan-
ted fate determination post-printing [20, 21]. There-
fore, the successful use of iPSCs requires
biofabrication techniques that not only minimize
harmful forces and exposure to stress, but also con-
currently select the appropriate culture conditions to
achieve the desired, differentiated cellular product.
Here we demonstrate the adaptation of a commer-
cially available ‘off the shelf’ extrusion based 3D prin-
ter (Felix 3.0) into a functional, high-resolution,
extrusion based bioprinter/bioplotter. Furthermore,
we report a goal-based, computational modeling
approach to optimize the biofabrication of high reso-
lution, fragile cell transfer without the use of encapsu-
lating hydrogels to maintain the pluripotency of
printed hiPSCs. We experimentally quantified the
functional limitations of micro-extrusion based bio-
printing by exploring relationships among parameters
such as micro-needle geometry, infusion flow rate,
printed cell resolution, cell viability and the retention
of functional differentiation capacity. We show via
both finite element method (FEM) and physical cell-
extrusion bioprinting experiments that the use of
deposition systems with a sharp reduction in inlet dia-
meter coupled to a long, narrow microneedle (such as
those found in ‘luer-lock’ syringe systems) generate
greater amounts of detrimental forces than those with
a gently tapered, conical needle geometry. We also
demonstrate the ability of our system to print sensitive
hiPSCswithout affecting their pluripotency.With new
maker movements taking hold [22], the use of prin-
table components for accessible bioprinting holds the
possibility of making truly transparent and transpor-
table scientific advancements in this field a reality. To
this end, we chose an open-source 3D printer, and
have provided open access to all of our modifications
through our website (http://ww2.odu.edu/~psachs/
Sachs_Lab/3D_BioPrinter.html). By lowering the
barrier of entry for these complex tools, research in
laboratories across the world will be able to design stu-
dies to not only improve the engineering of tissues, but
also improve the in vitro study of biological processes
such as development and tumorgenesis.
2.Materials andmethods
2.1. Cell culture
GFP labeled rat epithelial cells and GFP labeledMDA-
MB-468 mammary epithelial cells were cultured in a
75 cm2 flask in a mixture of Dulbecco’s modified
Eagle’s medium and Ham’s F12 medium (DMEM/
F12), 10% FBS and 1%ABAM (ThermoFisher). MCF-
12a cells were purchased from ATCC and cultured in
75 cm2 flask in DMEM/F12, supplemented with
20 ng ml−1 hEGF, 0.01 mgml−1 bovine insulin,
500 ng ml−1 hydrocortisone, 5% Horse Serum,
0.01 mgml−1 bovine insulin and 1% ABAM. Estab-
lished human induced pluripotent stem cells lines
(hiPSC) were generated from BJ fibroblasts through
sendai virus reprogramming [23] and cultured on
Geltrex matrix (ThermoFisher) with essential 8 med-
ium (ThermoFisher) and passaged manually with a
pulled glass ‘knife’ to avoid culture induced genomic
instability. All cells were cultured at 37.0 °C, and
5.0%CO2.
2.2. Bioprinting system
We have developed a microextrusion based bioprint-
ing system that is capable of extruding biopolymer
2
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solutions and living cells for freeform construction of
3D tissue scaffolds. This was achieved by modifying a
consumer-based 3D printer, Felix 3.0 (FELIXrobotics,
NL). The machine has listed print resolutions of
13 μm, 13 μm, and 0.39 μm for the x, y, and z axes,
respectively. All 3D printed components of the deposi-
tion system were designed in-house using Solidworks
CAD software and printed using PLA or ABS using the
3D printer and are available for download at (http://
ww2.odu.edu/~psachs/Sachs_Lab/3D_BioPrinter.
html). The deposition apparatus, designed to replace
the plastic-extruding print head, mounts to the stock
printer’s x-axis mounting bracket. The apparatus is
capable of housing a variety of tools through a library
of part specific, 3D printed inserts. The system is
powered by aNEMA17 hybrid bipolar steppingmotor
with an integrated threaded rod (Pololu, USA, item
no. 2268). The traveling nut moved 40 μm per full
step. The stepper motor has a 1.8° step angle (200
steps/revolution) and each phase draws 1.7 A at 2.8 V,
allowing for a holding torque of 3.7 kg cm (51 oz-in).
Therefore, 1 revolution equaled 8000 μm of linear
travel. The Felix 3.0’s motor driver is capable of using
1/16th microstepping routines, which provided reso-
lutions of 2.5 nl. The internal backlash of the motor is
3°. An 8 mm Simplicity® linear plain bearing (PCB
Linear) and an 8 mm stainless steel rod (McMaster
Car) provide support during linear displacements.
Experiments were defined by user inputs in a custom
Python and Matlab graphical user interface. The
software allows the user to manually or automatically
populate the wells of a specific plate with specific
droplet properties in 3D. The program would also
correct user operations that would place the needle tip
outside the boundaries of the available print areas. The
plotting locations and printing information was auto-
matically converted into g-code, loaded into the open-
sourced 3D printer controller Repetier Host, v.1.0 and
sent to the three axismicrocontroller.
2.3. Computationalmodeling
To quantify the relationship between fluid flows as a
function of microneedle geometry, idealized needle
geometry profiles were created in Solidworks Flow
Simulation (Dassault Systems, FR) and ComsolMulti-
physics. A goal-driven, computational analysis was
solved iteratively until flow parameters converged to a
certain solution/goal. The flow simulation utilized
solution-adaptive mesh refinement by splitting the
mesh cells in the high-gradient flow regions and
merging cells in the low-gradient flow regions. The
mesh was set to provide advanced, narrow-channel
refinement and also optimized thin wall resolutions.
The model was given conditions of steady, non-
Newtonian flow. The fluid used in our experiments
was given properties similar to blood. Three classes of
needle geometries were created representative of the
cylindrical needle geometry seen in stainless steel
‘luer-lock’ needles, a straight sided cone, or tapered
profilesmodeled as hyperbolas, parabolas or ellipses in
a similar manner to those seen in Martanto et al [24].
The inlet diameter for all needle conditions equaled
1 mm. The inlet volume boundary condition was
based on a constant volumetric flow rate of
0.1 mm3 s−1 (0.1 μl s−1). The diameter of the flow
outlet for all simulated conditions equaled 60 μm. The
flow outlet boundary condition was set to standard
atmospheric pressure, (101325 Pa). Our model condi-
tions accounted for the effects of gravity on cell settling
during needle inversion. We were able to specify wall
conditions by specifying values for accretion rates and
the normal and tangential coefficient of restitution.
The model features from three idealized needle
geometries that met our goal criteria (minimum shear
rate, pressure, and needle diameter while maximizing
flow rates) were then fabricated using a Sutter P97
programmable pipette puller and experimentally
quantified using our 3D printed, 3D bioprinter. An
optical encoder provided measurement scales to con-
firm needle profiles by visual analysis using Matlab
and ImageJ.
2.4. Cell viability assay
MCF-12a cells were suspended in media to a concen-
tration of 1× 106 cells ml–1. For all conditions,
approximately 25 μl of media was loaded into the
needle at a rate of 10 μl min−1 and dispensed intowells
of a 96well plate at one of four rates: 100, 400, 600, and
1000 μl min−1. All four rates were repeated in three
separate wells for a total of 12wells per condition. Four
needle conditions; no-tip (control), 28 gauge needle,
straight cone, and long tapered needle were tested,
giving a total of 48 wells. Post printing, cells were
maintained in a laboratory incubator at 37.0 °C, 5.0%
CO2. The viability was assessed 1 and 96 h post-
printing with AlamarBlue (ThermoFisher) bymeasur-
ing absorbance at 570 nm on a UV–Vis spectro-
photometer with SoftMax Pro 6.3. The sample mean
viability was calculated and normalized to the initial
viability of the no-tip control. Statistical significance
was determined using one-way ANOVA with Dun-
nett’s post hoc test (p< 0.05). Error bars on all figures
represent the standard deviation of the samplemean.
2.5. hiPSCbioprinting andTRA-1-81 staining of
hiPSCs
24 h prior to printing, 50 μl of a 1:1 mixture of growth
factor reduced Geltrex and differentiation suppressive
media (essential 8) was added to 12 wells of a standard
96 well plate and stored in a laboratory incubator at
37.0 °C, 5.0% CO2. Before cell plotting, the plate was
removed from the incubator and placed on the heated
print bed (37.0 °C). Single cell suspensions of hiPSCs
were obtained by rinsing pre-established hiPSC con-
taining wells with DMEM, followed by a 5 min
incubation with Accutase (Sigma-Aldrich). Cells were
3
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then centrifuged at 300 x g for 3 min; the resulting
pellet was diluted with essential 8 media to a concen-
tration of 4.5× 106 cells perml. Single cell suspensions
of hiPSCs were then loaded into a pulled glass needle
with a 40 μm tip diameter at 10 μl min−1. The plotting
routine was set to dispense a number of 100 nl droplets
200 μm (X, Y) apart and 250 μm (Z) from the bottom
of the plate. Post printing, 150 μl of essential 8 media
was overlaid on the gel and the plate was incubated at
37.0 °C, 5.0% CO2 for 7 d. The overlaid media was
changed every 24 h for 7 d. After 7 d in culture,
StainAlive TRA-1-81 antibody (Stemgent) was diluted
to a concentration of 5 μg ml−1 in fresh cell culture
medium. The antibody containingmedia was added to
the wells containing hiPSC printed aggregates and
incubated for 30 min in a laboratory incubator at
37.0 °C, 5.0% CO2. The medium was aspirated and
the wells were gently washed two times with cell
culturemedium. Fresh cell culturemediumwas added
to the wells and staining was examined using a Zeiss
axio-observer Z1fluorescentmicroscope.
2.6. Automated formation hiPSCs aggregates
Twenty four hours prior to printing, 50 μl of a 1:1
mixture of growth factor reduced Geltrex and differ-
entiation supportive media (10% FBS, 1% ABAM,
DMEM/F12) was added to 12 wells of a standard 96
well plate and stored in a laboratory incubator at
37.0 °C, 5.0% CO2. Before cell plotting, the plate was
removed from the incubator and placed on the heated
print bed (37.0 °C). Single cell suspensions of hiPSCs
were obtained by rinsing hiPSC containing wells with
DMEM, followed by a 5 min incubation with Accu-
tase (Sigma-Aldrich). Cells were then centrifuged at
300 x g for 3 min; the resulting pellet was diluted with
differentiation-supportivemedia to a concentration of
4.5× 106 cells per ml. These single cell suspensions of
hiPSCs were then loaded into a pulled glass needle
with a 40 μm tip diameter at 10 μl min−1. The plotting
routine was set to dispense a number of 100 nl droplets
200 μm (X, Y) apart and 250 μm (Z) from the plate
bottom into wells of a 96 well plate containing 50 μl of
a 1:1 mixture of growth factor reduced Geltrex and
differentiation supportivemedia. Immediately follow-
ing the plotting routine, the plate containing fabri-
cated hiPSC aggregates was incubated at 37.0 °C, 5.0%
CO2 for 7 d. 150 μl of differentiation supportivemedia
was overlaid on the gel post printing and changed
every 24 h for 7 d. Post-plotting, wells containing gel-
embedded hiPSC aggregates were monitored using
brightfield imaging every 30 min for 5 d using a
Lumascope 620microscope.
2.7. Formation of hiPSCEBs using hanging drop
method
The hiPSC single cell suspension used in the auto-
mated plotting experiment was diluted to 5× 105
cells ml–1. 1 μl samples of the diluted hiPSC single cell
suspension were then manually added to 20 μl of
differentiation-supportive media which had been pre-
viously pipetted onto the inside surface of a Petri dish
lid. The lid was then inverted to force cells to aggregate
due to the effects of gravity. The dish bottomwas filled
with the same media to prevent drying and stored in a
laboratory incubator for 7 d at 37.0 C, 5.0%CO2.
2.8. Gene expression assay of printed and hanging
drophiPSC aggregates
Total cellular RNA was isolated from 7 d old, 3D
printed hiPSC aggregates and hanging drop hiPSC EBs
with Trizol (Life-Technologies) according to manu-
facturer’s protocol. RNA quantification was deter-
mined by UV absorbance at 260 nm (A260 nm) on a
NanoDrop 2000 (Thermo Scientific). 5 μg of each
RNA sample was reverse transcribed into cDNA using
the High-Capacity cDNA Reverse Transcription Kit
(Thermo Fisher) according to manufacturer’s instruc-
tions. cDNA samples from established hiPSCs (con-
trol), printed hiPSCs and hanging drop EBs were
amplified and detected using TaqMan Gene Expres-
sion Assays for markers, HAND1 (Hs02330376_s1),
SOX17 (Hs00751752_s1), PAX3 (Hs00240950_m1),
NANOG (Hs04260366_g1), and the endogenous
housekeeping gene ACTB (Hs99999903_m1). Quanti-
tative Reverse Transcription PCR experiments were
conductedwith a StepOnePlus Real-TimePCRSystem
(Applied Biosystems). TaqMan Fast Advanced Master
Mix was used in conjunction with TaqMan Gene
Expression assays per manufacturer’s protocol. All
experimental reactions were completed in triplicate
and the relative quantity was calculated using the
2−(ΔΔct) method. All statistical comparisons were
madewith ANOVA (p< 0.01).
3. Results
3.1. Bioprinter fabrication
Most well-appointed commercial 3D bioprinters cost
well above the budget limits of many biological
laboratories wishing to use these tools for cell based
experimentation. To address this we aimed to use
readily available parts to adapt an ‘off the shelf’
extrusion-based 3D printer into a high-precision,
open-sourced bioprinter. The unmodified Felix has a
positional resolution within a reasonable range for
single cell deposition.We used computer-aided design
(CAD) software to design a microextrusion apparatus
to replace the plastic extruding print head, figure 1(a).
These prototype parts were then 3D printed using the
standard extrusion system on the unmodified Felix
system, figure 1(b). To better serve our experimental
requirements, the system was designed to be inter-
changeable withmore than one type of plunger-driven
syringe system (several sizes of luer-lock syringe,
microcapillary pipettes, etc), figure 1(c). Our 3D
printed parts were highly accurate with regard to
4
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matching specified part dimensions, figure 1(d).
Furthermore, no measurable differences among
printed components were observed confirming the
Felix’s stated precision and accuracy.
3.2. Needle optimization through computational
modeling
As we intended to use our 3D bioprinter to print
liquids containing both biomolecules and sensitive cell
types, we recognized the need to model various needle
variants to determine the flow characteristics, includ-
ing shear rates in the needle tip. To do this, we
designed several permutations of needle types using
3D CAD software. The needle types of our initial
simulations included a model of a conventional
syringe-needle system, and needles with various
lengths and internal slopes with a straight-sided
triangular, T, or parabolic curved, C, geometry. The
straight triangular needle is characterized by having a
linear change in needle diameter, whereas the curved
needle types resemble more of a parabolic curve with a
slope that is greater than one (see [24] for more
information). We then measured the impact of needle
geometry on fluid dynamics during the bioprinting
process using computer generated,multiphysics simu-
lations. To provide a better understanding of needle
clogging due to cell accretion, we traced particle
streamlines of 10 μm wide particles, the typical
diameter of cells, through our needle models under
conditions that favored aggregation. The aggregation
of cells within the needle tip occurred by increasing
particle accretion rates and lowering the normal and
tangential coefficients of restitution at the needle wall.
Particle studies then indicated a large population of
cells with velocities near zero in the narrowest region
of the conventional needle configuration, figure 2(a).
These populations were not observed in triangular
needle configurations, figure 2(b). This indicated the
conventional needle type leads to a higher rate of cell
aggregation and needle clogging when compared to a
tapered, triangular needle. Furthermore, the results
from the flow simulations also indicated cells traveling
through the center of the conventional configuration
have a higher velocity than those in the center of the
straight triangular configuration, 75 mm s−1 versus
55 mm s−1, respectively. Interestingly, when the dura-
tion of the simulation was increased, we observed
particle streamlines in the conventional configuration
that travel away from the needle entrance.
The velocity profile established in a given flow
situation strongly influences themass transfer process.
For the process of bioplotting, the mass transfer pro-
cess is primarily dependent on the ability of the ejected
droplet to remain inside the surrounding material.
Furthermore, the needle tip should also impart mini-
mal damage to the gel during the plotting procedures.
Figure 1.CADdesign and 3Dprinting of bioprintermodifications to the Felix 3.0: (a)CADmodel of x-axis bioprinting adapter with
lead screw and syringe adapter for injector depression. (b)Resultant 3D-printed bioprinter injector adaptermounted to the x-axis of
3Dprinter with steppermotor installed for injector actuation. (c)CADmodels for syringe adapter inserts for securing the body of the
injector (bottom row) and clips for holding the plunger (top row). (d)Example of a 3Dprinted insert and clip usedwith the pulled
glass-microcapillary pipette injector andTeflon plunger.
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Therefore, the best needle type should be narrow
enough to penetrate the gel without disturbing sur-
rounding material, limit unfavorable processing con-
ditions for fragile cell types, and perform the printing
process without clogging. To examine this concept a
comparison between triangular, T, and curved, C, nee-
dles of increasing length was performed. The resulting
data indicated all T type needles have a higher average
velocity than C type needles. Interestingly, we found
the maximum velocity was greatest in the 1 mm long
needle type (table 1). Yet, the 1 mm long T type
requires lower force and results in a lower maximum
pressure than both 7 mm long needle types. Given the
inlet diameter for these simulations equaled 1 mm, the
1 mm long straight needle represents a 1:1 geometry
near that of a straight-sided cone. We also found coni-
cally shaped needles generate less internal pressure
than straight-sided triangular needles of the same
length. Numerical results indicate needle length has a
significant effect on total pressure. Interestingly, the
7 mmC needle type, showed a sharp reduction in total
pressure when compared to a straight-triangular nee-
dle type of the same length, 7 mm T. We found this
relationship to suggest needle length and needle type
has an effect on total pressure. While longer needle
lengths resulted in higher total pressures, the C type
needles were always lower in total pressure than the
straight-triangular type of the same length. Overall,
the results show that as the cross-sectional area of the
microneedle decreases, the maximum fluid velocity
increases and the pressure decreases.
Results from our flow simulations also found the
shear rate generated in conventional systems is greater
than shear rates observed in needles with tapered geo-
metries. These simulations show how as the extent and
shape of the flow passages change, the cells within the
fluids are subjected to stretching in one or more
dimensions. It should be noted the shear rate in the
conventional system was highest in the region imme-
diately after the abrupt reduction in needle diameter,
and in the region nearest the needle tip, suggestive of
elongational flow, figure 3(a). On the other hand, the
shear rate observed in needles with a straight trian-
gular taper is greatest in the region of the tip,
figure 3(b). Furthermore, we were able to generate this
post-constriction increase in shear rate in tapered nee-
dle types by increasing the length of the narrowest
section of the needle (data not shown). Using the
results from our simulations, three microneedle geo-
metry types were fabricated using a programmable
pipette puller. The programmable pipette puller and
our glass pipettes provided the ideal process to fabri-
cate of many custom needle configurations. To pro-
vide a comparison to the standard 28 gauge stainless
steel needle, these three types are shown in figure 3(c).











Figure 2.CFDparticle studies of the bio-deposition process under conditions that favor aggregation.Heatmap graphical
representations of particle velocities of 10 μmwide particles, the typical diameter of cells, traveling through idealizedmicroneedle
geometries representing: (a) conventional ‘luer-lock’needle type and (b) triangular needle configurations under conditions of steady,
non-Newtonian flowwith a constant volumetric flow rate of 0.1 mm3 s−1. The inlet and exit diameter for all needle conditions
equaled 1 mmand 60 μm, respectively. The flowoutlet boundary condition equaled standard atmospheric pressure (101325 Pa). Our
model conditions accounted for the effects of gravity. The exit velocity for the conventional ‘luer-lock’ condition (a)was 72 mm s−1,
whereas the triangular needle (b)was 55 mm s−1. The aggregation of cells within the needle tipwas encouraged by increasing particle
accretion rates and lowering the normal and tangential coefficients of restitution at the needle wall. Under these conditions, particles
near the exit of themicroneedle with zero velocity (shown in blue)were only observed in the conventional ‘luer-lock’ geometry types.
Table 1.Analytical solutions toCFD simulations of the bioprinting process using variousmicroneedle geometries.
Needle type Avg. pressure (kPa) Max. pressure (kPa) Avg. velocity (mm s−1) Max. velocity (mm s−1) Applied force (N)
7.0 mmTa 107.679 107.712 17.109 719.010 0.001 017 152
7.0 mmCb 103.505 103.526 15.339 711.593 0.000 352 58
1.0 mmTa 103.109 103.124 17.569 1271.699 0.000 283 929
1.0 mmCb 102.862 102.870 11.146 1249.325 0.000 139 728
0.75 mmTa 102.200 102.227 17.176 837.077 0.000 139 728
0.75 mmCb 101.683 101.691 11.157 746.944 0.000 056 1757
a Needle tips with a straight-sided, triangular appearance.
b Needle tips with curved geometries.
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to right, are examples of a 3 mm long straight-trian-
gular needle with a 150 μm tip diameter, a 5 mm long
curved needle with 150 μmdiameter, and a 6 mm long
curved needle with a 75 μmdiameter. One notable dif-
ference between the conventional needle and our
pulled needles is the length of the narrow channel. The
narrowest section of the conventional, stainless-steel
needle is typically 30 mm long, which is five times
longer than the typical length of our fabricated needles
(∼5 mm). Using needles with geometric features that
minimize the amount of time cells travel through these
narrow channels presents fewer opportunities for cells
to aggregate and a concurrent reduction in detri-
mental forces, both of which are a significant process
improvement. Furthermore, by fabricating the needle
from borosilicate glass tubes we were able to retain a
high degree of structural rigidity without the need to
increase the thickness of the needle wall. That is to say,
the ratio of the outer-diameter to the inner-diameter is
substantially lower for the glass needles than the con-
ventional steel needle, figure 3(c). This provided a sub-
stantial increase to the print resolution of our system.
The conventional needle was not capable of the same
degree of positional precision and repeatability as the
glass needle. When compared to glass, the thin stain-
less-steel needle has more elastic material properties,
which made it prone to bending during the printing
process. The nonlinearity across the needle meant the
needle tip was not always precisely above the target
site. This also negatively impacted the plotting process
by introducing insertion angles that were not always
perpendicular to the target site, which resulted in
increased disruption of the gelled material surround-
ing the target site. While we initially began our experi-
mentation with a narrower 30 gauge needle, the high
concentration of cells required for the printing process
made printing through such long narrow needles
unreliable due to frequent clogging. Through further
experimentation, we found a 28 gauge needle pro-
vided the required performance for our experiments.
Despite the 25 μm increase in interior needle diameter
than a 30 gauge needle, using 28 gauge needles did not
completely alleviate the clogging issue. It should also
be noted that the 28 gauge needle has an inner dia-
meter four times larger than the pulled glass micro-
needles. Overall, borosilicate glass tubes which
combine the needle and syringe into a single, rigid part
with geometry optimized for fragile cell transfer are
superior to conventional, stainless-steel needles.
3.3. Cell viability assay
To further study the effects of microneedle geometry
on the dynamic process of bioprinting, we sought to
determine if there was an appreciable real world
impact seen when applying the various needle permu-
tations. To accomplish this we used an immortalized,
non-tumorigenic, adult mammary epithelial cell line,
MCF-12A. Following injection into 96-well plates, the
Figure 3. Shear rate results fromCFDparticle studies of the bio-deposition process using variousmicroneedle geometries. 10 μm
wide particles, the typical diameter of cells, traveling through idealizedmicroneedle geometries representing: (a) conventional
‘luer-lock’ needle geometry, (b) triangular needle geometry under conditions of steady, non-Newtonian flowwith a constant
volumetric flow rate of 0.1 mm3 s−1 (0.1 μl s−1). The inlet and exit diameter for all needle conditions equaled 1 mmand 60 μm,
respectively. The flowoutlet boundary condition equaled standard atmospheric pressure (101325 Pa). Ourmodel conditions
accounted for the effects of gravity. Simulated results indicated cell sized particles travel through areas with greater amounts of shear in
conventional ‘luer-lock’needles than straight-sided triangular needles. (c)Examples of pulled-glassmicrocapillary tubes with tapered
geometries (left to right): 3 mm long straight-triangular needle with a 150 μmtip diameter, 5 mm long curved needlewith 150 μm
diameter, 6 mm long curved needlewith a 75 μmdiameter, and 28 gauge stainless steel needle.
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cells were assayed for metabolic activity 1 h post
printing and then again 96 h post printing. Results
from the AlamarBlue assay indicated a significant
reduction in the amount of viable cells 1 h post-
printing for the syringe-28 Gauge needle condition
compared to control (no-tip) for two printing speeds,
600 μl min−1, 1000 μl min−1 (figure 4(a), *p < 0.05).
This experimental data supports results from our
simulations. A significant increase in viability was also
observed 96 h post-printing for the 1000 μl min−1,
straight-cone or triangular condition, compared to
control, (figure 4(b), *p< 0.05). These data confirmed
that while survival was comparable amongst many of
our needle designs, when print speeds increase, a
corresponding reduction in viability is observed in
needles that were previously shown to have a greater
shear rate. This is likely due to the initial stress placed
upon the cells resulting in a lack of cellular division
during the 96 h post-print.
3.4. Print resolution verification
As the diameter of most somatic human cells are
between 10–30 μm, and the spacing between injection
points is largely determined by the diameter of the
needle, we wished to generate a system capable of
printing as close to this target range as possible. Precise
placement of different cell types or signalingmolecules
and other various components in as close proximity to
a ‘cellular’ resolution would be highly advantageous.
To test the limits of printed cell resolution and the
possibility of obtaining single cell extrusion events, we
injected 1 nl of media containing GFP labeled MDA-
MB-468 cells into ∼1 mm thick Geltrex, figure 5(a).
To provide better illustration of this process,
figures 5(b)–(d) represent GFP, bright-field, and
combined channels of the single cell ‘events’ our
system generates. Analysis of the single-cell extrusion
events indicated our system is capable of reliably
extruding single cells. To further examine the capacity
of our printer, we quantified the distances among
printed cell locations using ImageJ software to define
positional precision. This analysis found the X and Y
resolution to be ±6.34 μm and ±9.71 μm, respec-
tively, confirming the factory-listed resolutions
(13 μm× 13 μm (±6.5 μm)). In addition to positional
precision, bioprinting techniques also require precise
control over the amount of extruded material. To
determine how effective our printer was at controlling
the amount of extruded materials, we generated a
gradient of GFP labeled rat epithelial cells by decreas-
ing the extrusion amount in each successive row from
70 nl , 60 nl, 50 nl and 10 nl, figure 5(e). Uponmanual
counting, the number of cells within each print
location, from top to bottom, averaged 68± 6, 62± 4,
51 ± 4, and 8 ± 2, respectively. The theoretical cell
concentration in the media used to generate the
gradient study in figure 5(c) represented a distribution
of 1 cell per nl. Given this information, we observed an
overall congruency among the number of counted
cells and the directed extrusion amount. The variation
in the number of printed cells was greatest in row one,
the group with the largest extrusion amount. We
expected to observe greater variation in the number of
cells in the larger extrusion conditions because our
approach is largely based on pairing the probability of
a single cell within a specified extrusion amount. The
duration of the plotting procedure was less than 3 min.
Therefore, it appears printing within this timewindow
prevents confounding variables such as cell settling
due to gravity. The results in figure 5 provide informa-
tion on the ability of the system to repeatedly handle
volumes from 1 to 100 nl. Furthermore, they provide
Figure 4.MCF-12AAlamarBlue cell viability studies post-printing. (a)AlamarBlue reduction 1 h post-printing (*p< 0.05), (b)
AlamarBlue reduction 96 h post printing (*p< 0.05).MCF-12a cells were suspended inmedia to a concentration of 1× 106 cells ml–1.
For all conditions, approximately 25 μl of cell containingmediawas loaded into the needle at a rate of 10 μl min−1 and dispensed into
wells of a 96well plate at one of four rates: 100, 400, 600, and 1000 μl min−1. All four rates were repeated in three separate wells for a
total of 12wells per condition. Four needle conditions; no-tip (control), 28 gauge needle, straight cone, and long tapered needle were
tested, giving a total of 48wells. The samplemean viability was calculated and normalized to the initial viability of the no-tip control.
Statistical significance was determined using one-wayANOVAwithDunnett’s post hoc test (p< 0.05). Error bars,mean± s.d.
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insight into our systems ability to repeatedly extrude a
set number of cells within a single target volume.
3.5. Bioprinted hiPSCs
Bioprinting of pluripotent cells in order to generate
biomimetic embryonal structures is a crucial step for
diseasemodeling and tissue engineering. However, the
printing process can physically alter the cellular
structure resulting in unwanted shifts in gene expres-
sion and protein function. Having previously deter-
mined our extrusion system has minimal shear and
pressure related effects on cells, we hypothesized that
our system would have no negative impact on hiPSCs
printed into either differentiation or pluripotent-
conducive environments. We first wanted to deter-
mine if our systemwas capable of printing hiPSCs that
retain their pluripotency post-printing. To test this we
used our pulled glass needles to print 3D aggregates of
hiPSCs using pluripotency-conducive E8 media into
growth factor reduced Geltrex. Following 7 d post
printing of the iPSCs we then stained the aggregates
with pluripotency antibody TRA-1-81, a cell surface
marker specific for pluripotent cells (figure 6(a)),
confirming that our system is capable of retaining a
pluripotent state.
We next wanted to test the ability of our system to
generate differentiated EBs. To confirm the differ-
entiation of our injected hiPSCs, we compared their
gene expression changes to the gold-standard hang-
ing-drop EB method. We therefore printed hiPSC in
Geltrex (500 cells per injection) with FBS containing
media and in tandem deposited hiPSCs on culture
flask lids (500 cells per droplet) and following lid
inversion, allowed them to incubate at 5% CO2, 37 °C
for 7 d. To then evaluate and confirm that the differ-
entiated EBs were similar in nature, mRNA was
extracted and qRT-PCRwas performed. The results of
our gene expression assays indicated a significant up-
regulation of differentiation markers for the endo-
derm (Sox17), mesoderm (Hand1), and ectodermal
(PAX3) lineages in the printed hiPSC group as com-
pared to non-printed, non-differentiated control
hiPSCs, (figure 6(c), *p< 0.01). Interestingly, the gene
expression was also significantly upregulated as com-
pared to the hanging drop EBs, possibly indicating a
more mature differentiation. To observe the motility
and growth of our injected hiPSCs we followed the
injections with time-lapse imaging. This revealed the
initial formation of spheroids followed by the dynamic
growth of secondary and tertiary structures similar to
budding, elongation, and increased complexity over
7 d, figure 6(d) (supp.movie 1–3).
4.Discussion
Using 3D printed parts and highly accessible hard-
ware, we were able to reliably print at precise XYZ
locations within 3D hydrogels cellular aggregates in
various concentrationswith injection volumes ranging
Figure 5.Printer resolution and functional limitations. (a) 1 nl extrusion, each containing a single GFP labeledMDA-MB-468 cell
printed into∼1 mmthickGeltrex (scale bar 100 μm). (b)GFP channel of single-cell extrusion event usingMDA-MB-468 cells (scale
bar 100 μm). (c)Bright-field channel of the same single-cel extrusion event (scale bar 100 μm). (d)CombinedGFP and bright-field
(scale bar 100 μm). (e)Decreasing gradient ofGFP labeled rat epithelial cells generated by extruding 70 μl, 60 μl, 50 μl, and 10 nl
(scale bar 300 μm).
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from 1 nl to hundreds of microliters with spatial
resolution only limited by the diameter of the needle
itself. Currently, our system is able to obtain prints
containing 1 cell per injection event. We attribute part
of this cellular resolution to the use of stepper motors,
which are ideally suited for extrusion-based bioprint-
ing as they offer a unique solution for open-loop
position control. Specifically, the output shaft rotates
in a series of discrete angular intervals, or steps, each
time a command pulse is received, therefore the exact
displacement of the shaft is known at all times. This
feedback allows the user to modify the acceleration
rates and deceleration rates of the fluid while traveling
through the needle at all times during 3D printing
experiments. This forward/reverse positional control
gives an additional level of process control unseen in
solenoid valve based systems that have been previously
examined [13, 16]. Additionally, the shaft of themotor
will remain at a specific step until another step pulse is
supplied, which provides exceptional positional con-
trol and eliminates leaks from the needle tip.
It is known that the fluid characteristics during
syringe needle flow introduce three main types of
mechanical forces capable of cell disruption: (i) shear-
ing forces due to linear shear flow, (ii) pressure drop
across the cell, and (iii) stretching forces due to exten-
sional flow [20]. Numerous studies have implemented
novel hydrogel-vehicle systems as a sacrificial, viscoe-
lastic material to encapsulate cells and alter the dis-
tribution of damaging mechanical forces experienced
during flow [20, 21, 25, 26]. Yet, despite encapsulation
in alginate solution (1.5% w/v), one study found ink-
jet dispensing pressure demonstrated a more sig-
nificant effect on cell viability than nozzle diameter;
constructs printed at 40 psi showed a 38.75 percent
reduction in viability compared to those printed at
5 psi [27]. Recently, Faulkner-Jones et al found an
effect of nozzle length and dispensing pressure on
human pluripotent stem cell viability; cells printed
through an 8.9 mm long nozzle showed higher levels
of viability than those in a 24.4 mm long nozzle [16].
We therefore tested if injection systems which impart
the lowest amount of overall shear would be preferable
for fragile cell transfer; and those systems which mini-
mize the amount of time a cell flows through the high-
est shear-rate section of the needle (or nozzle) would
be preferable to systems in which the cells spend a
greater amount of time flowing through high shear-
rate sections.
To investigate this we compared the force distribu-
tion of several needle types using FEM to identify fea-
tures related to cell damaging forces. This approach
enabled us to examine the development of these forces
throughout the bioprinting process using systems of
equations that included boundary conditions with slip
along the needle wall. Mathematical models have been
developed which indicate tapered needle geometries
result in different cell damages due to the conical geo-
metry and changing force distribution in the needle.
Billiet et al found a significant pressure and needle type
dependence on cell viability; at low inlet pressure,
conically shaped needles are preferred over
Figure 6. 3Dprinted hiPSCs. (a)Presence of green fluorescence due toTRA-1-81 binding to undifferentiated pluripotent cells in 3D
printed hiPSC aggregate 7 d post printing. (b)Bright-field image of 3Dprinted hiPSC aggregate. (c)Gene expression profiles of hiPSCs
usingmarkers for ectoderm (Pax 3), mesoderm (Hand 1), endoderm (Sox-17), and pluripotentmarker (Nanog) (*p< 0.01). Error
bars,mean± s.d. (d) 7 d-time lapse images of bioprinted hiPSCs in a 1:1mixture ofGeltrex/differentiation supportivemedia reveal
dynamic growth and increased complexity (left to right, top-left taken at t0) (scale bars 100 μm).
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cylindrically shaped ones [28]. However, they found
this advantage disappears at higher inlet pressures, yet
they did not vary the length of the needle or the angle
of the needle tip in their studies. Our investigation
found short, conically shaped needles are preferred
over long cylindrically shaped geometries due to a
favorable axial pressure gradient that requires less
energy to accelerate fluid through the microneedle,
and a substantial reduction in the amount of shear in
the needle tip.When the cross-section of a pipe gradu-
ally narrows, such as the straight-triangular needle in
figure 3(b), the streamlines follow closely along the
contours of the pipe and virtually no extra frictional
losses are observed. By generating a more even trans-
ition to the narrow diameter needle tip, tapered nee-
dles provide a better-suited environment for fragile
cell transfer. Furthermore, when this transition is
abrupt, such as those of the conventional ‘luer-lock’
configurations, the inner diameter of the syringe is
notably larger than the needle tip, and the cells
undergo a correspondingly abrupt increase in linear
velocity as they pass into the needle, also known as
extensional flow. This convergence to a small point,
coupled with the increased shear seen in the long,
cylindrical needle appear to be the two components
that contribute to unfavorable printing conditions
related to fragile cell transfer. With these hypothetical
variations in mind, we confirmed that syringe-needle
extrusion rates greater than 600 μl min−1 have an
effect on cell viability when compared to no-tip con-
trols. Additionally, when examining the 96 h post
injection viability it was clear that extrusion velocity
and the needle geometry had a significant effect on
growth.
3D based organogenesis from hiPSCs is one of the
most exciting areas of tissue engineering and biofabri-
cation. The approach of self-organizing pluripotent
cells into functional differentiated cells not only repre-
sents a better model of natural processes, but also
serves as a highly efficient method of organogenesis.
Our investigation provides essential information on
how biofabrication parameters such as needle geo-
metry and flow rates may affect the post-printing
behavior of hiPSCs. Positive TRA-1-81 staining of
hiPSC printed aggregates in pluripotent supportive
environments, indicate our printing device was cap-
able of delivering unaltered pluripotent cells into 3D
environments without the need for protective encap-
sulation strategies. Furthermore, when these same
pluripotent cells were injected into differentiation sig-
naling environments, the printed hiPSC aggregates
generated small, spherical cluster of cells that then
began to depart from the main body and appeared to
wander through the 3D matrix. Interestingly the gene
expression analysis revealed a significant increase in
differentiation and pluripotent markers as compared
to both the non-differentiated iPSC and the standard
EB formation methods. It is known that the physical
features of the surrounding structure affect the
differentiation of stem cells, therefore, one way to
explain the increase in relative expression of these
genes in the printed group, when compared to the
non-printed control, may be due to an interaction
among the hiPSCs and 3D gel-matrix. Instead of
directly mixing these highly sensitive cell types with
the scaffold materials required to generate 3D struc-
tures, our approach sought to prevent these types of
cell-structure interactions by placing cells into specific
3D locations inside a pre-formed, 3D architecture.
Because these cells are not directly included in the fab-
rication process, which often requires the structural
change of the scaffold from a liquid to a gel post-print-
ing, this method attempts to eliminate these types of
extraneous variables in order to better understand the
differentiation pathways that iPSCs follow when
placed in a 3D environment. This feature could expose
many future advantages that would establish a better
understanding of normal tissue and organ develop-
ment. This holds many benefits for developing models
that better mimic human disease as well as affording
us the capability to design and construct accurate
replacement cellular constructs.
5. Conclusion
Here we have described a simple process for develop-
ment of an accessible and high precision 3D bioprinter
through modification of an inexpensive ‘off the shelf’
3D printer. The bioprinter uses a pulled-glass capillary
pipette to minimize shear stress and optimize posi-
tional control and precision. This minimal cellular
impact enabled our system to successfully print
hiPSCs while maintaining their pluripotency. Addi-
tionally, we were able to print hiPSCs into differentia-
tion conducive environments that generated cells of all
three developmental germ-layers. To the best of our
knowledge, our system is the first 3D printed,
bioprinting system to reliably achieve single cell print
resolutions within 50 μm resolution, while also exert-
ing minimal unwanted impact on the cells viability
and post-printing fate. Furthermore, our system is
highly modifiable and can be fabricated for use on any
3D printer. This type of system is ideal for adaptation
by both basic and clinical research laboratories for the
study of cellular interactions and/or tissue engineering
applications. We would like to note that our bioprint-
ing system upgrade cost less than $200 (not including
the off-the-shelf printer, which could be substituted
for other models). Our hope is our system, or similar
systemswill lower the technical and financial hurdle of
3D bioprinting to any laboratory with an interest in
furthering the developments of 3D cellular biology. As
open-sourced projects have developed advanced soft-
ware systems such as Unix, and hardware solutions
such as Arduino and Raspberry Pi, here we institute
similar initiatives within the field of biofabrication. To
facilitate this, our models are freely available for
11
Biofabrication 8 (2016) 025017 J AReid et alIOP Publishing 
download from our repository (http://ww2.odu.edu/
~psachs/Sachs_Lab/3D_BioPrinter.html).
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